Comparison of effects of remazolam benzenesulfonate and propofol in BIS-guided hysteroscopic anesthesia: a multicentre, randomized, single-blind, noninfertility study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047432

Enrollment

Unknown

Registered

2021-06-18

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases requiring hysteroscopy

Interventions

Experimental group:Anesthesia with rimazolam

Control Group:Anesthesia with propofol

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who intend to undergo hysteroscopic surgery, voluntarily participate in the study and sign informed consent form; 2. Aged 18 to 65 years; 3. BMI 18.5-30 kg/m^2; 4. ASA I-II grade.

Exclusion criteria

Exclusion criteria: 1. Uncontrolled hypertension ; 2. Cardiac dysfunction (ejection fraction 150 umol / L) ; 6. Preoperative use of benzodiazepines or opioids ; 7. Myopathy or diabetes ; 8. History of chronic pain. History of drug or alcohol abuse ; 9. Not cooperating with those who are unable to communicate.

Design outcomes

Primary

Measure	Time frame
Sedative onset time;awakening time;	—

Secondary

Measure	Time frame
Incidence of adverse events;	—

Countries

China

Contacts

Public ContactLin Jingyan

Affiliated Hospital of North Sichuan Medical College

419931094@qq.com+86 15983771119

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026